e-Therapeutics plc

Receive alerts
Market Cap:
£11.02 m
52 weeks high
52 weeks low

Viewing results 1-25 of 133


e-therapeutics teams up with a top-five pharma company for neurodegenerative diseases project

The 12-month tie-up with the unnamed drug giant will showcase the research group's network-driven drug discovery approach...

on 08/13/2019

New tool from e-Therapeutics will analyse genomics of type-2 diabetes patients to find new drugs

A new contract extends last December's agreement with Novo Nordisk for another six months to June 2020...

on 08/01/2019

e-Therapeutics hopeful of securing more collaboration deals in 2019

Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more collaboration deals in the coming months...

on 04/12/2019

e-Therapeutics eyes further partnerships and possibly M&A to fully exploit its potential

Its most significant landmark of the year just gone was a collaboration with Danish multi-national Novo Nordisk focusing on type-2 diabetes...

on 03/05/2019

Danish drugs giant Novo Nordisk to use e-Therapeutics’ technology in search for new diabetes treatments

e-Therapeutics will be reimbursed for its work under this collaboration and Novo Nordisk has the option to license relevant IP generated under the collaboration...

on 12/10/2018

e-Therapeutics and C4x Discovery team up to find new Parkinson’s treatments

By combining both of their technologies, the companies think they can identify better treatments for Parkinson’s disease...

on 12/06/2018

e-therapeutics sees biopharma sector get in tune with its way of thinking

E-therapeutics believes it is now focused on the right activities...

on 10/29/2018

E-therapeutics loss narrows in half year as it files new patent for drug discovery platform

The biotech and pharmaceuticals firm reported a pre-tax loss of £2.7mln for the period, almost £1mln less than the £3.6mln loss reported a year ago...

on 10/04/2018

e-Therapeutics and C4X Discovery to collaborate on Parkinson's Disease treatment

The collaboration will see e-Therapeutics combine its Network-Driven Drug Discovery (NDD) platform with C4XD's Taxonomy3 technology...

on 05/01/2018

e-Therapeutics - FY 2018 Results Show Good Progress

e-therapeutics reported results for the full year to Jan 31st 2018; business updates reflect good progress on the main research programs. Cash balance of £9.6mn was slightly higher than we expected, thanks to careful cost management.   ...

on 03/28/2018

e-therapeutics sees full-year operating loss significantly reduced as turnaround continues under new CEO

Ray Barlow, who joined as e-therapeutics CEO on 6 April 2017 commented: "During the course of the year, we have continued the turnaround of the business. We are now focused on the right activities"...

on 03/27/2018

e-Therapeutics enhances its AI technology capabilities as it signs two collaboration deals

The tie-ups are with University of Cambridge spin-out Intellegens and Manchester-based Biorelate...

on 01/15/2018

e-Therapeutics - Capital Network: Undervalued Stock with a Unique Approach to Drug Discovery

e-Therapeutics (LON:ETX) focuses on the discovery of  new drugs in a more efficient and effective way and aims to be a valued partner to address the productivity challenge that the pharma industry faces. e-Therapeutics (LON:ETX) has developed a novel and unique in-silico approach to drug discovery: starting......

on 10/25/2017

e-Therapeutics sees cash burn and losses fall in first half as new boss’ plans take shape

CEO Ray Barlow only joined the company earlier this year, but he’s already making his mark...

on 09/26/2017

e-Therapeutics pioneering the development of improved new drugs with a focus on cancer

E-Therapeutics’ network-driven drug discovery platform looks at the broader interactions within disease mechanisms...

on 08/17/2017

e-Therapeutics unveils results of its strategic review under new chief executive

e-Therapeutics plans to control its costs by reducing the number of self-funded discovery programmes from six to two...

on 07/24/2017

Drug developer e-Therapeutics streamlines its operation

“We are now focusing on our core strengths around our unique drug discovery platform and the discovery of novel preclinical drugs," said chairman Iain Ross....

on 04/19/2017

First day for new e-Therapeutics boss

Dr Raymond Barlow arrives from Amgen, where he held a senior role...

on 04/06/2017